What is he best known for?
The fields of study he is best known for:
Harutaka Katano mainly focuses on Virology, Pathology, Virus, Kaposi's sarcoma and Antigen.
His work on Primary effusion lymphoma as part of general Virology research is frequently linked to Materials science, thereby connecting diverse disciplines of science.
He interconnects Aids patients and Morphology in the investigation of issues within Pathology.
His Virus study improves the overall literature in Immunology.
The concepts of his Kaposi's sarcoma study are interwoven with issues in Antibody, Seroprevalence and Sarcoma.
His work is dedicated to discovering how Antigen, Immunohistochemistry are connected with Virus Activation and other disciplines.
His most cited work include:
- The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan (409 citations)
- Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I (225 citations)
- Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. (218 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Virology, Pathology, Virus, Immunology and Lymphoma.
His Virology research is multidisciplinary, relying on both Antibody, Serology, Antigen and Kaposi's sarcoma.
His Pathology study frequently draws connections to adjacent fields such as Lung.
His study looks at the relationship between Virus and fields such as Polymerase chain reaction, as well as how they intersect with chemical problems.
The various areas that Harutaka Katano examines in his Immunology study include Internal medicine and Acquired immunodeficiency syndrome.
In Primary effusion lymphoma, Harutaka Katano works on issues like Cancer research, which are connected to Apoptosis and Programmed cell death.
He most often published in these fields:
- Virology (52.06%)
- Pathology (31.96%)
- Virus (27.84%)
What were the highlights of his more recent work (between 2018-2021)?
- Virology (52.06%)
- Severe acute respiratory syndrome coronavirus 2 (3.61%)
- Coronavirus disease 2019 (2.58%)
In recent papers he was focusing on the following fields of study:
Harutaka Katano spends much of his time researching Virology, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, Coronavirus and Virus.
Many of his research projects under Virology are closely connected to Polyomavirus associated nephropathy with Polyomavirus associated nephropathy, tying the diverse disciplines of science together.
His studies in Coronavirus integrate themes in fields like Pandemic, Betacoronavirus, Polymerase chain reaction and Pneumonia.
His research in Virus intersects with topics in Antibody and Endocytosis.
His Disease research focuses on subjects like Autopsy, which are linked to Immunohistochemistry and Antigen.
His Hematology study in the realm of Immunology connects with subjects such as Viral hemorrhagic fever.
Between 2018 and 2021, his most popular works were:
- Development of Genetic Diagnostic Methods for Novel Coronavirus 2019 (nCoV-2019) in Japan (184 citations)
- Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan. (61 citations)
- Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas. (19 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Severe acute respiratory syndrome coronavirus 2, Virology, Severe fever with thrombocytopenia syndrome, Coronavirus disease 2019 and Coronavirus.
He has included themes like Acute kidney injury, Hemodynamics and Renal replacement therapy, Intensive care medicine in his Severe acute respiratory syndrome coronavirus 2 study.
His biological study spans a wide range of topics, including Deep sequencing and Mycoplasma.
His research investigates the connection between Severe fever with thrombocytopenia syndrome and topics such as CD79A that intersect with issues in Immunohistochemistry and Pathology.
Harutaka Katano combines subjects such as Malaise, Acute arthritis and Critically ill with his study of Coronavirus disease 2019.
His Coronavirus study integrates concerns from other disciplines, such as Betacoronavirus, Antigen and Autopsy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
